not cause retro-orbital pain, and characteristically is associated with persistent arthralgia. Management is supportive. The first live recombinant tetravalent dengue vaccine was licensed in December 2015 for individuals ages 9 to 45 years living in endemic areas. Several other vaccines are in phase 3 trials.
Malaria is a protozoal infection transmitted by the bite of the female Anopheles mosquito. The World Health Organization (WHO) estimated 214 million cases worldwide and 438,000 deaths, mostly in children, in 2015. About 1,500 imported cases are diagnosed in the United States each year. Malaria should be considered in all febrile travelers returning from endemic areas within the past year, regardless of a history of malaria prophylaxis. The 5 viral species that commonly infect humans are Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi. The clinical manifestations depend on the infecting species and the immune status of the infected individual. P falciparum most commonly causes severe disease. Classic symptoms are high fever with chills, rigor, sweats, and headache. Early diagnosis is important due to the potential for rapid fatality. Peripheral thick and thin blood smears are the gold standard for diagnosis. Rapid diagnostic test kits available in resource-limited settings can detect malarial antigens within minutes but cannot determine the species or quantify parasitemia.
Neuroinvasive arboviruses are a significant cause of pediatric disease, with more than 1,200 cases of central nervous system infection and 22 deaths in the past decade. La Crosse virus (65%) and West Nile virus (41%) are the leading causes of pediatric neuroinvasive arboviral disease. Eastern equine encephalitis has the highest case fatality rate. La Crosse virus is a California serogroup bunyavirus found in the central and eastern United States. The incidence of infection in endemic areas (20-30 cases per 100,000 per year) exceeds that of bacterial meningitis. Aedes triseriatus is the primary vector. La Crosse virus encephalitis primarily affects children younger than age 15 years. Most infected cases (80%-90%) involve a mild course with headache, fever, and vomiting. The infection can progress to severe disease with seizures and coma in 10% to 20% of cases. West Nile virus is a flavivirus that is vectored through the Culex mosquito, with birds as the natural reservoir. It is present throughout the United States. Although 80% of infected individuals are asymptomatic, those who are symptomatic present with mild flulike illness and rash. Fewer than 1% develop neuroinvasive disease, with the highest incidence in older adults. Infection with these neuroinvasive arboviruses can be diagnosed by testing serum or cerebrospinal fluid to detect virus-specific immunoglobulin (Ig)M and neutralizing antibodies.
Education of families and caregivers plays an important role in prevention of mosquito-borne infection. Specific measures include eliminating mosquito breeding sites by drainage and removal of receptacles for standing water around the home. Among the large-scale public health measures during outbreaks are drainage of standing water, use of larvicides in waters that are sources of mosquitoes, and use of pesticides to control adult mosquitoes. The use of window and door screens and limiting outdoor activities at dusk and dawn can reduce exposure. Barriers such as mosquito nets and screens for baby strollers and clothing to cover areas of exposed skin are protective. The United States Environmental Protection Agency has approved the use of DEET (N,N-diethyl-meta-toluamide) in children as an effective repellent.
The American Academy of Pediatrics recommends that insect repellants not be used in children younger than age 2 months and that DEET at maximum concentration of up to 30% be used in those older than age 2 months. These repellants should not be applied over cuts or sunburned skin. Permethrin (a synthetic pyrethroid) is an effective repellant that can be sprayed on clothing but should not be sprayed on the skin. In spite of all control measures, mosquitoes and mosquito-borne infections remain a significant public health challenge even today.
COMMENT: The recent Zika outbreaks in South America and subsequent transmission to the Caribbean and United
States have put mosquito-borne infections back in the news. These outbreaks led to a designation of a WHO Public Health Emergency of International Concern, influenced attendance at the Rio de Janeiro Olympics, and altered travel plans to affected areas. As of November 23, 2016, the CDC website noted that travel-related cases of ZIKV have been reported throughout the United States, with the highest rates in New York, Florida, and California. This outbreak was especially concerning because of the vertical transmission associated with microcephaly and the worrisome sexual transmission. This outbreak also called to attention the decrease in public health interventions of prevention, including environmental, biologic, and chemical control for mosquito-borne infections, since the 1940s. The range of manifestations of mosquito-borne infections from infected children being asymptomatic to exhibiting serious infection reminds me of questions that Barton Childs, a famous geneticist and role model at Johns Hopkins, would ask. He would encourage all of us to contemplate these questions when considering an illness in a child: Why this child, why this disease, and why now? Factors that are probably at play with mosquito-borne infections include prior exposure; individual health status, such as malnutrition, chronic illness, and immunodeficiency status; and genetic factors and predisposition that currently are being identified. Prevention remains the key, and we as pediatricians must make sure we reinforce the preventive strategies that Drs Rajagopalan and Ilboudo have outlined in this In Brief. Vaccine development continues and may prove helpful in the future. 
